A growing body of research indicates that psychedelics are safe and potentially effective as treatments for a wide range of psychiatric disorders. Between 2019 and 2020, investments ballooned from about $60 million to over $600 million.
Compound DMT
Visit article
Category Press Release
Country Canada
Companies Featured
Entheon BiomedicalEntheon Biomedical is a listed (CSE) company that aims to develop DMT for addiction treatment.